サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1179897

血管造影装置の世界市場-2023-2030

Global Angiography Devices Market - 2023-2030
出版日: | 発行: DataM Intelligence | ページ情報: 英文 200 Pages | 納期: 約2営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=155.86円
血管造影装置の世界市場-2023-2030
出版日: 2023年01月05日
発行: DataM Intelligence
ページ情報: 英文 200 Pages
納期: 約2営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

市場概要

血管造影装置の世界市場規模は、予測期間（2023～2030年）においてCAGR6.2%で成長するとされています。

血管造影装置は、体内の血管や臓器の内部（内腔）を可視化するための医療用画像機器であり、特に動脈、静脈、心室が注目されています。血管造影システム、カテーテル、ガイドワイヤー、バルーン、造影剤、血管閉鎖装置、血管造影用アクセサリーなどが含まれます。

市場力学

心血管疾患の症例の増加、高齢者人口の増加、ライフスタイルの変化、心血管疾患に関する意識の高まり、市場の開拓は、世界の血管造影装置市場の成長を促進すると期待されています。

新製品の発売は、予測期間中に世界の血管造影装置市場を押し上げます。

血管造影のための新製品の導入は、予測期間中に世界の血管造影装置市場を押し上げます。例えば、2020年の北米放射線学会（RSNA）バーチャルミーティングにおいて、GEヘルスケアはAllia IGS 7血管撮影システムを公開しました。同システムは、人工知能を活用し、回転式血管造影の利用を増幅させる。また、2021年11月、ロイヤル・フィリップスは、ハイブリッド・アンジオCTスイートに画期的なスペクトルCTイメージング技術を搭載し、インターベンション医療に対する認識を明らかにしました。フィリップスは、同社独自のスペクトルCT 7500システムと画像誘導治療システムAzurion、FlexArmを単一のインターベンショナルスイートソリューションに統合することにより、インターベンショニストがこれら2つの重要な画像モダリティにテーブルサイドから瞬時にアクセスできるようになると期待しています。

さらに、2022年4月、GEヘルスケアは、Discovery IGS 740モバイルアンギオグラフィシステムを発売しました。アンテザー方式のDiscovery IGS 740は、優れたルームデザインとシッティングの柔軟性を実現します。Discoveryのレールフリー設計と調節可能なワイドボアCアームポジショニングは、施術者に優れた快適性と制御性を提供します。さらに、大型の検出器により、2Dおよび3Dで広範囲の解剖学的構造をカバーします。同様に、2022年11月、ジェネシス・メテック・グループは、TriReme Medical LLCが設計した、表在性大腿動脈および膝窩動脈の末梢動脈疾患患者の治療に適応されるチョコレートタッチ薬剤コーティングバルーンPTAカテーテルのFDA（食品医薬品局）の承認を取得しました。したがって、前述のデータは、製品導入の増加が予測期間において世界の血管造影装置の成長を促進することを示しています。

厳しい規制と高コストが血管造影装置の世界市場の成長を阻害しています。

しかし、主要な市場プレーヤーによる市場からの再発する製品リコールは、予測期間中に世界の血管造影装置の成長を抑制しています。例えば、2021年7月、メドトロニック社は、血管造影時にカテーテルを血管系に入れるために使用するガイドワイヤーコンポーネントが、病院に出荷される前に滅菌されていなかったため、54,997個をリコールしました。また、2021年9月、Cordis社は、X線不透過マーカーバンド付きの血管造影用カテーテル「SUPER TORQUE MB」について、マーカーバンドが移動または誤挿入する可能性があるとして、リコールしました。FDAはこれを最も深刻なリコールであるクラスiと認定しています。

COVID-19の影響分析

COVID-19の大流行は、世界の血管造影装置市場に悪影響を及ぼしました。なぜなら、大流行の間、血管造影手術が大幅に減少したからです。例えば、英国心臓血管インターベンション学会は、パンデミックによる閉鎖期間中に英国で行われたすべての経皮的冠動脈インターベンション（PCI）を、パンデミック前のPCI件数と比較するレトロスペクティブ分析を実施しました。その結果、PCIは49％減少し、中でも安定狭心症は66％減少し、ST上昇型MI（STEMI）に対するPCIは33％減少しました。さらに、パンデミックは人々の健康的なライフスタイルへの見方を変え、心血管疾患の症例を減少させたため、世界の血管造影装置にマイナスの影響を及ぼしました。

目次

  • 調査手法
  • 調査目的および調査範囲

第2章 市場の定義と概要

第3章 エグゼクティブサマリー

第4章 市場力学

  • 市場影響要因
    • 促進要因
      • 心・血管系疾患の増加
      • 老年人口の増加
      • 市場戦略
    • 抑制要因
      • 製品市場のリコール
      • 厳しい規制
    • ビジネスチャンス
    • 影響分析

第5章 産業分析

  • ポーターのファイブフォース分析
  • サプライチェーン分析
  • 規制分析

第6章 COVID-19の分析

  • COVID-19の市場分析
    • COVID-19以前の市場シナリオ
    • COVID-19の現在の市場シナリオ
    • COVID-19の後、または将来のシナリオ
  • COVID-19の中での価格ダイナミクス
  • 需要-供給スペクトラム
  • パンデミック時の市場に関連する政府の取り組み
  • メーカーの戦略的取り組み
  • まとめ

第7章 製品タイプ別

  • 血管造影システム
  • カテーテル
  • ガイドワイヤー
  • バルーン
  • 造影剤
  • 血管閉鎖器具
  • 血管造影用アクセサリー

第8章 アプリケーションタイプ別

  • 診断用
  • 治療用

第9章 技術タイプ別

  • X線
  • MRI
  • CT

第10章 手技別

  • 冠動脈
  • 血管内治療
  • 脳神経血管

第11章 地域別

  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
    • その他欧州
  • 南米
    • ブラジル
    • アルゼンチン
    • その他の南米地域
  • アジア太平洋地域
    • 中国
    • インド
    • 日本
    • オーストラリア
    • その他アジア太平洋地域
  • 中東・アフリカ地域

第12章 競合情勢

  • 主な展開と戦略
  • 企業シェア分析
  • 製品ベンチマーク

第13章 企業プロファイル

  • Medtronic Plc
    • 企業概要
    • 製品ポートフォリオと説明
    • 主なハイライト
    • 財務概要
  • Abbott
  • Boston Scientific Corporation
  • Teleflex Incorporated
  • B.Barun Melsungen
  • Siemens Healthineers
  • Lepu Medical
  • GE Healthcare
  • Haemonetics Corporation
  • Cook Medical Inc.

第14章 DataM

目次
Product Code: DMMD1651

Market Overview

The global angiography devices market size was valued at US$ YY million in 2022 and is estimated to reach US$ YY million by 2030, growing at a CAGR of 6.2% during the forecast period (2023-2030).

Angiography devices are medical imaging devices used to visualize the inside, or lumen, of blood vessels and organs of the body, with a particular interest in the arteries, veins, and heart chambers. These include Angiography Systems, Catheters, Guidewires, Balloons, Contrast Media, Vascular Closure Devices, and Angiography Accessories.

Market Dynamics

The rising cases of cardiovascular diseases, growing geriatric populations, lifestyle changes, increasing awareness about cardiovascular diseases, and market developments are expected to fuel the global angiography devices market growth.

The new product launches boost the global angiography devices market during the forecast period.

The new product introduction for angiography boosts the global angiography devices market during the forecast period. For instance, in the Radiological Society of North America (RSNA) virtual meeting in 2020, GE Healthcare revealed its Allia IGS 7 angiography system. The system utilizes artificial intelligence to amplify the use of rotational angiography. Also, in November 2021, Royal Philips disclosed its perception of interventional medicine by including its breakthrough spectral CT imaging technology into a hybrid Angio CT suite. Philips expects to deliver interventionalists instantaneous table-side access to these two key imaging modalities by integrating the company's unique Spectral CT 7500 system and its Image-Guided Therapy System, Azurion, with FlexArm in a single interventional suite solution.

Additionally, in April 2022, GE Healthcare launched its Discovery IGS 740 mobile angiography system. The untethered Discovery IGS 740 delivers excellent room design and sitting flexibility. The Discovery's rail-free design and adjustable wide-bore C-arm positioning deliver exceptional comfort and control to the practitioners. Moreover, its large detector covers extensive anatomies in both 2D and 3D. Likewise, in November 2022, Genesis MedTech Group received the Food and Drug Administration (FDA) approval for its Chocolate Touch Drug-coated Balloon PTA Catheter, designed by TriReme Medical LLC, indicated for the treatment of patients with peripheral artery disease in the superficial femoral artery and the popliteal artery. Thus, the mentioned data indicates that the increasing product introductions drive the growth of global angiography devices in the forecasted period.

The stringent regulations and high costs hinder the global angiography devices market growth.

However, the reoccurring product recalls from the market by key market players are restraining the growth of global angiography devices during the forecasted period. For instance, in July 2021, Medtronic's recalled 54,997 guidewire components used during angiography to place catheters into the vascular system because the devices were not sterilized before being shipped to hospitals. Also, in September 2021, Cordis Recalled its SUPER TORQUE MB angiographic catheter with radiopaque marker bands due to the potential for marker bands to move or mislodge. The FDA has recognized this as a Class I recall, the most serious recall.

COVID-19 Impact Analysis

The COVID-19 pandemic had a negative impact on the global Angiography Devices market since, during the pandemic, there was a large downfall in Angiography procedures. For instance, the British Cardiovascular Interventional society performed a retrospective analysis of all percutaneous coronary interventions (PCI) performed in the United Kingdom during the lockdown imposed by the pandemic in comparison with PCI volumes in the pre-pandemic period. The retrospective analysis concluded that there was 49% less PCI, with stable angina being hit the hardest, showing a 66% reduction, while the PCI for ST-elevation MI (STEMI) was down by 33%. Furthermore, the pandemic changed people's perspective toward healthy lifestyle choices, which caused a reduction in the cases of cardiovascular diseases, therefore impacting global angiography devices negatively.

Segment Analysis

Coronary heart disease is predicted to have a high demand during the forecast period (2022-2029).

Coronary heart disease is a heart disease in which the heart's arteries are unable to deliver sufficiently oxygen-rich blood to the heart muscles. It is the top reason for death. The reason for coronary heart disease relies on the type. Coronary artery disease is usually induced by cholesterol, a waxy substance that assembles up inside the lining of the coronary arteries, creating plaque. This buildup can partly or completely block blood flow in the heart's large arteries. The coronary microvascular condition occurs when the heart's tiny blood vessels do not typically work. For most individuals, coronary heart disease is preventable with a heart-healthy lifestyle.

Since the number of coronary heart disease cases is growing, coronary angiography is estimated to dominate the global angiography devices market throughout the forecast period. For instance, the American Heart Association estimated that globally, 244.1 million people were living with ischemic heart disease (IHD) in 2020, and it was more dominant in males than in females (141.0 and 103.1 million people, respectively). The highest prevalence rates of IHD were in North Africa and the Middle East, Central and South Asia, and Eastern Europe, and IHD mortality rates were highest in North Africa, the Middle East, Eastern Europe, and Central Asia in 2020. Thus, the mentioned data indicates that coronary angiography will dominate the global angiography devices market during the forecast period.

Geographical Analysis

North America is predicted to command the global angiography devices market.

North America is estimated to hold a large market over the forecast period (2022-2029) because of the growing cases of cardiovascular conditions and the existence of key market players in this region. For instance, according to the CDC, a U.S. American dies every 34 seconds because of cardiovascular disease. Cardiovascular disease caused over 697,000 deaths in 2020. Moreover, the existence of key market players such as Abbott, Haemonetics Corporation, Boston Scientific Corporation, Teleflex Incorporated, Medtronic, and Cook Medical Inc., having considerable percentages of the global angiography devices market through different market strategies, are based in the United States, secures the dominance of this region over the global angiography devices market. For instance, in May 2022, Teleflex Incorporated, a leading global medical technology provider, was granted Health Canada approval for its MANTA Vascular Closure Device, the first commercially available biomechanical vascular closure device developed particularly for large bore femoral arterial access site closure. This approval marks an essential landmark in the regulatory strategy to extend the availability of the MANTA Device globally and delivers access to another uniquely developed device from Teleflex to Canadian clinicians.

Also, in January 2021, Haemonetics Corporation ("Haemonetics"), a global medical technology company concentrated on delivering inventive medical solutions to drive better patient outcomes, acquired a privately-held Cardiva Medical, Inc. ("Cardiva"), an industry-leading manufacturer of vascular closure systems based in Santa Clara, California. Haemonetics enhances its penetration into the large and growing interventional cardiology and electrophysiology markets with this acquisition. Therefore, the data indicate that North America Holds most of the global market.

Competitive Landscape

The major global angiography devices market players are Abbott, Boston Scientific Corporation, Teleflex Incorporated, Medtronic, B.Barun Melsungen, Siemens Healthineers, Lepu Medical, GE Healthcare, Haemonetics Corporation, and Cook Medical Inc. The key players are adopting various strategies such as product launches, mergers & acquisitions, partnerships, and collaborations, contributing to the growth of the Angiography Devices market globally. For instance, in October 2022, Lepu Medical obtained the MDR certificate issued by the BSI Netherlands Notified Body (2797) for its Ultraskin Hydrophilic Guide Wire and approved it for sale in the EU market. The certificate is valid for five years. Ultraskin Hydrophilic Guide Wire is the second product of Lepu Medical's high-risk class III product certified under MDR.

Medtronic, Plc.

Overview:

Medtronic plc is Ireland based American medical device company. Medtronic was founded in 1949 and is headquartered in Minneapolis, Minnesota, United States. Medtronics deals with four different businesses: the Minimally Invasive Therapies Group, the Diabetes Group, the Restorative Therapies Group, and the Cardiac and Vascular Group.

Product Portfolio:

The product portfolio of Medtronic, Plc. for angiography devices contains Launcher: A coronary guide catheter comes with the performance advantages expected from a market leader, including a wide variety of curve shapes for transradial and femoral percutaneous coronary intervention (PCI).

The global angiography devices market report would provide access to approximately 40+ market data tables, 45+ figures, and in the range of 200 (approximate) pages.

Table of Contents

Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

4. Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. The Growing Prevalence of Cardio-vascular diseases
      • 4.1.1.2. Growing Geriatric Population
      • 4.1.1.3. Market Strategies
    • 4.1.2. Restraints
      • 4.1.2.1. Product Market Recalls
      • 4.1.2.2. Stringent Regulation
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Regulatory Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturer's Strategic Initiatives
  • 6.6. Conclusion

7. By Product Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 7.1.2. Market Attractiveness Index, By Product Type
  • 7.2. Angiography Systems
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis, US$ Million, 2021-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 7.3. Catheters
  • 7.4. Guidewires
  • 7.5. Balloons
  • 7.6. Contrast Media
  • 7.7. Vascular Closure Devices
  • 7.8. Angiography Accessories

8. By Application Type

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application Type
    • 8.1.2. Market Attractiveness Index, By Application Type
  • 8.2. Diagnostic
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis, US$ Million, 2021-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 8.3. Therapeutic

9. By Technology Type

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology Type
    • 9.1.2. Market Attractiveness Index, By Technology Type
  • 9.2. X-Ray
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis, US$ Million, 2021-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 9.3. MRI
  • 9.4. CT

10. By Procedure

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Procedure
    • 10.1.2. Market Attractiveness Index, By Procedure
  • 10.2. Coronary
    • 10.2.1. Introduction
    • 10.2.2. Market Size Analysis, US$ Million, 2021-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 10.3. Endovascular
  • 10.4. Neurovascular

11. By Region

  • 11.1. Introduction
    • 11.1.1. Market Size Analysis, US$ Million, 2021-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
    • 11.1.2. Market Attractiveness Index, By Region
  • 11.2. North America
    • 11.2.1. Introduction
    • 11.2.2. Key Region-Specific Dynamics
    • 11.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 11.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application Type
    • 11.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology Type
    • 11.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Procedure
    • 11.2.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.2.7.1. U.S.
      • 11.2.7.2. Canada
      • 11.2.7.3. Mexico
  • 11.3. Europe
    • 11.3.1. Introduction
    • 11.3.2. Key Region-Specific Dynamics
    • 11.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 11.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application Type
    • 11.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology Type
    • 11.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Procedure
    • 11.3.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.3.7.1. Germany
      • 11.3.7.2. U.K.
      • 11.3.7.3. France
      • 11.3.7.4. Italy
      • 11.3.7.5. Spain
      • 11.3.7.6. Rest of Europe
  • 11.4. South America
    • 11.4.1. Introduction
    • 11.4.2. Key Region-Specific Dynamics
    • 11.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 11.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application Type
    • 11.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology Type
    • 11.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Procedure
    • 11.4.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.4.7.1. Brazil
      • 11.4.7.2. Argentina
      • 11.4.7.3. Rest of South America
  • 11.5. Asia Pacific
    • 11.5.1. Introduction
    • 11.5.2. Key Region-Specific Dynamics
    • 11.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 11.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application Type
    • 11.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology Type
    • 11.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Procedure
    • 11.5.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.5.7.1. China
      • 11.5.7.2. India
      • 11.5.7.3. Japan
      • 11.5.7.4. Australia
      • 11.5.7.5. Rest of Asia Pacific
  • 11.6. Middle East and Africa
    • 11.6.1. Introduction
    • 11.6.2. Key Region-Specific Dynamics
    • 11.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 11.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application Type
    • 11.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology Type
    • 11.6.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Procedure

12. Competitive Landscape

  • 12.1. Key Developments and Strategies
  • 12.2. Company Share Analysis
  • 12.3. Product Benchmarking

13. Company Profiles

  • 13.1. Medtronic Plc
    • 13.1.1. Company Overview
    • 13.1.2. Product Portfolio and Description
    • 13.1.3. Key Highlights
    • 13.1.4. Financial Overview
  • 13.2. Abbott
  • 13.3. Boston Scientific Corporation
  • 13.4. Teleflex Incorporated
  • 13.5. B.Barun Melsungen
  • 13.6. Siemens Healthineers
  • 13.7. Lepu Medical
  • 13.8. GE Healthcare
  • 13.9. Haemonetics Corporation
  • 13.10. Cook Medical Inc.

LIST NOT EXHAUSTIVE

14. DataM

  • 14.1. Appendix
  • 14.2. About Us and Services
  • 14.3. Contact Us